Scintigraphic evaluation in rabbits of nasal drug delivery systems based on carbopol 971p(®) and carboxymethylcellulose

Journal of Controlled Release

Volumn 68, Issue 2, 2000, Pages 207-214

  Ugwoke, Michael Ikechukwu ^a   Agu, Remigius Uchenna ^a   Vanbilloen, Hubert ^b   Baetens, Jan ^b   Augustijns, Patrick ^a   Verbeke, Norbert ^a   Mortelmans, Luc ^b   Verbruggen, Alfons ^b   Kinget, Renaat ^a   Bormans, Guy ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

99mTc labeled colloidal albumin; Apomorphine; Carbopol; Carboxymethylcellulose; Gamma scintigraphy; Mucociliary clearance; Nasal drug delivery

Indexed keywords

ALBUMIN TC 99M; APOMORPHINE; BLANOSE; CARBOMER; CARBOPOL 971P; CARBOXYMETHYLCELLULOSE; LACTOSE; UNCLASSIFIED DRUG;

AERATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; GAMMA SCINTIGRAPHY; ISOTOPE LABELING; MALE; NONHUMAN; NOSE CAVITY; NOSE MUCOSA; PRIORITY JOURNAL; RABBIT;

ANIMALS; APOMORPHINE; CARBOXYMETHYLCELLULOSE; DRUG DELIVERY SYSTEMS; MALE; MUCOCILIARY CLEARANCE; NASAL MUCOSA; POLYVINYLS; RABBITS; TECHNETIUM;

EID: 0034632958     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(00)00258-3     Document Type: Article

References (34)

1. Chien Y.W. Biopharmaceutics basis for transmucosal delivery. S.T.P. Pharma. Sci. 4:1995;257-275.
2. Provasi D., De Ascentiis A., Minutello A., Colombo P., Catellani D.L. Nasal powders of progesterone: manufacturing and bioavailability. Eur. J. Pharm. Biopharm. 40:1994;223-227.
3. Illum L., Jorgensen H., Bisgaard H., Krogsgaard O., Rossing N. Bioadhesive microspheres as a potential nasal drug delivery system. Int. J. Pharm. 39:1987;189-199.
4. Gizurason S. The relevance of nasal physiology to the design of drug absorption studies. Adv. Drug Del. Rev. 11:1993;329-347.
5. Schipper N.G.M., Verhoef J.C., Merkus F.W.H.M. The nasal mucociliary clearance: Relevance to nasal drug delivery. Pharm. Res. 8:1991;807-814.
6. Dondeti P., Zia H., Needham T.E. Bioadhesive and formulation parameters affecting nasal absorption. Int. J. Pharm. 127:1996;115-133.
7. Hochman J., Artursson P. Mechanism of absorption enhancement and tight junction regulation. J. Controlled Release. 29:1994;253-267.
8. Holmberg K., Bjork E., Bake B., Edman P. Influence of degradable starch microspheres on human nasal mucosa. Rhinology. 32:1994;74-77.
9. Bjork E., Isaksson U., Edman P., Artursson P. Starch microspheres induce pulsatile delivery of drugs and peptides across the epithelial barrier by reversible separation of the tight junction. J. Drug Targeting. 2:1995;501-507.
10. Nagai T., Nishimoto Y., Nambu N., Suzuki Y., Sekine K. Powder dosage form of insulin for nasal administration. J. Controlled Release. 1:1984;15-22.
11. Critchley H., Davis S.S., Farraj N.F., Illum L. Nasal absorption of desmopressin in rats and sheep. Effect of a bioadhesive microsphere delivery system. J. Pharm. Pharmacol. 46:1994;651-656.
12. Leußen H.L., Lehr C.M., Rentel C.O., Noach A.B.J., de Boer A.G., Verhoef J.C., Junginger H.E. Bioadhesive polymers for the peroral delivery of peptide drugs. J. Controlled Release. 29:1994;329-338.
13. Park H., Robinson J.R. Physicochemical properties of water insoluble polymers important to mucin/epithelial adhesion. J. Controlled Release. 2:1985;47-57.
14. Ponchel G., Touchard F., Duchene D., Peppas N.A. Bioadhesive analysis of controlled-release systems. I. Fracture and interpenetration analysis in poly(acrylic acid)-containing systems. J. Controlled Release. 5:1987;121-141.
15. Vidgren P., Vidgren M., Arppe J., Hakuli T., Laine E., Paronen P. In vitro evaluation of spray-dried mucoadhesive microspheres for nasal administration. Drug Dev. Ind. Pharm. 18:1992;581-597.
16. Mortazavi A., Smart J.D. An investigation into the role of water movement and mucus gel dehydration in mucoadhesion. J. Controlled Release. 25:1993;197-203.
17. Vidgren P., Vidgren M., Vainio P., Nuutinen J., Paronen P. Double-labelling technique in the evaluation of nasal mucoadhesion of disodium cromoglycate microspheres. Int. J. Pharm. 73:1991;131-136.
18. Pennington A.K., Ratcliffe J.H., Wilson C.G., Hardy J.G. The influence of solution viscosity on nasal spray deposition and clearance. Int. J. Pharm. 43:1988;221-224.
19. Zhou M., Donovan M.D. Intranasal mucociliary clearance of putative bioadhesive polymer gels. Int. J. Pharm. 135:1996;115-125.
20. Nakamura F., Ohta R., Machida Y., Nagai T. In vitro and in vivo nasal mucoadhesion of some water-soluble polymers. Int. J. Pharm. 134:1996;173-181.
21. Gancher S.T., Nutt J.G., Woodward W.R. Absorption of apomorphine by various routes in Parkinsonism. Movement Disord. 6:1991;212-216.
22. Sam E., Jeanjean A.P., Maloteaux J.M., Verbeke N. Apomorphine pharmacokinetics in Parkinsonism after intranasal and subcutaneous application. Eur. J. Drug Metab. Pharmacokin. 20:1995;27-33.
23. E. Puchelle, Nasal mucociliary clearance, in: D. Duchêne (Ed.), Buccal and Nasal Administration as an Alternative to Parenteral Administration. Editions de Santé, Paris, 1992, pp. 29-39.
24. Puchelle E., Aug F., Pham Q.T., Bertrand A. Comparison of three methods for measuring nasal mucociliary clearance in man. Acta Otolaryngol. 91:1981;297-303.
25. C.G. Wilson, N. Washington, Scintigraphic studies of nasal and buccal administration, in: D. Duchêne (Ed.), Buccal and Nasal Administration as an Alternative to Parenteral Administration. Editions de Santé, Paris, 1992, pp. 174-187.
26. Ingels K., Van Hoorn V., Obrie E., Osmanagaoglu K. A modified technetium-99m isotope test to measure nasal mucociliary transport: comparison with the saccharine-dye test. Eur. Arch. Otorhinolaryngol. 252:1995;340-343.
27. Sam E., Augustijns P., Verbeke N. Stability of apomorphine in plasma and its determination by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. B. 658:1994;311-317.
28. Ugwoke M.I. Development and Evaluation of Controlled Release Drug Delivery Systems of Apomorphine. 1999;Leuven University Press, Leuven.
29. Ugwoke M.I., Sam E., Van Den Mooter G., Verbeke N., Kinget R. Nasal mucoadhesive delivery systems of the anti-Parkinsonian drug, apomorphine: influence of drug-loading on in vitro and in vivo release in rabbits. Int. J. Pharm. 181:1999;125-138.
30. M.I. Ugwoke, G. Kaufmann, N. Verbeke, R. Kinget, Intranasal bioavailability of apomorphine from carboxymethylcellulose-based drug delivery systems. Submitted.
31. Aoki F.I., Crawley J.C.W. Distribution and removal of human serum albumin-technetium-99m instilled intranasally. Br. J. Clin. Pharmacol. 3:1976;869-878.
32. Liverside G.G., Wilson C.G., Sternson L., Kinter L.B. Nasal delivery of a vasopressin antagonist in dogs. J. Appl. Physiol. 64:1988;377-383.
33. Dittigen M., Durrani M., Lehmann K. Acrylic polymers, a review of pharmaceutical applications. S.T.P. Pharma. 7:1997;403-437.
34. Ugwoke M.I., Agu R.U., Jorissen M., et al. Nasal toxicological investigations of Carbopol 971P formulation of apomorphine: effects on ciliary beat frequency of human nasal primary cell culture and in vivo on rabbit nasal mucosa. Eur. J. Pharm. Sci. 9:2000;387-396.